Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting  Monday April 22, 2024

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment  Tuesday April 16, 2024

Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?  Tuesday April 09, 2024

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.  Saturday March 30, 2024

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Tuesday March 26, 2024

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer  Wednesday March 13, 2024

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds  Saturday March 09, 2024

Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts  Monday March 04, 2024

Q4 2023 Voyager Therapeutics Inc Earnings Call  Thursday February 29, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript  Thursday February 29, 2024

Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position  Wednesday February 28, 2024

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results  Wednesday February 28, 2024

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich's Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment  Monday February 26, 2024

Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?  Monday February 26, 2024

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast  Wednesday February 21, 2024

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer's Disease and Advances Program into Late Research  Tuesday February 20, 2024

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference  Wednesday February 07, 2024

While institutions own 30% of Voyager Therapeutics, Inc. (NASDAQ:VYGR), individual investors are its largest shareholders with 42% ownership  Friday January 26, 2024

Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024  Friday January 12, 2024

Voyager Therapeutics Announces Pricing of Public Offering  Friday January 05, 2024